Drug Type Small molecule drug |
Synonyms Felbinac (JP17/USAN/INN), Felbinac tape, Felbinac transdermal + [18] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Sep 1986), |
Regulation- |
Molecular FormulaC14H12O2 |
InChIKeyQRZAKQDHEVVFRX-UHFFFAOYSA-N |
CAS Registry5728-52-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Low Back Pain | Japan | 28 Feb 1989 | |
Bursitis | Japan | 25 Sep 1986 | |
Musculoskeletal Pain | Japan | 25 Sep 1986 | |
Osteoarthritis | Japan | 25 Sep 1986 | |
Post-traumatic pain | Japan | 25 Sep 1986 | |
Tenosynovitis | Japan | 25 Sep 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Phase 2 | China | 21 Jan 2014 | |
Soft Tissue Injuries | Discovery | China | 15 Nov 2011 |